Clinical Trial Update: Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and tolerability of hypertonic saline given via intraosseous access for stroke-related conditions; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Edema
• Intracranial Hypotension
• Stroke

Drugs mentioned

• Hypertonic Saline (Hypertonic saline)

Snippet

Sponsor: Ohio State University | Conditions: Stroke, Intracranial Hypotension | Phase 2 | Status: COMPLETED | Results posted: 2019-07-09